Fig. 2
From: Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans
miR-182 expression between AA and EA patients from the SFVAMC cohort. A qPCR analysis for miR-182 expression in EA (n = 42) and AA (n = 40) from the SFVAMC cohort. B ROC curve analysis between AA and EA patient samples. C and D Biochemical recurrence (BCR)-free survival curves for two groups defined by low and high expression of miR-182 in AA (C) or EA (D) patients with prostate cancer. E miR-182 expression levels in prostate cell lines RWPE-1, DU-145, LNCaP, and MDA-PCa-2b assessed by qPCR. *, P < 0.05. Data are presented mean ± SD